245 related articles for article (PubMed ID: 30274824)
1. Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.
Hsueh YH; Chen HW; Syu BJ; Lin CI; Leung PSC; Gershwin ME; Chuang YH
J Autoimmun; 2018 Dec; 95():159-170. PubMed ID: 30274824
[TBL] [Abstract][Full Text] [Related]
2. AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis.
Hsueh YH; Chang YN; Loh CE; Gershwin ME; Chuang YH
J Autoimmun; 2016 Jan; 66():89-97. PubMed ID: 26537567
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
[TBL] [Abstract][Full Text] [Related]
4. Dual Roles of IFN-γ and IL-4 in the Natural History of Murine Autoimmune Cholangitis: IL-30 and Implications for Precision Medicine.
Syu BJ; Loh CE; Hsueh YH; Gershwin ME; Chuang YH
Sci Rep; 2016 Oct; 6():34884. PubMed ID: 27721424
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.
Chang CH; Chen YC; Yu YH; Tao MH; Leung PS; Ansari AA; Gershwin ME; Chuang YH
Clin Exp Immunol; 2014 Aug; 177(2):373-80. PubMed ID: 24547942
[TBL] [Abstract][Full Text] [Related]
6. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.
Ambrosini YM; Yang GX; Zhang W; Tsuda M; Shu S; Tsuneyama K; Leung PS; Ansari AA; Coppel RL; Gershwin ME
Clin Exp Immunol; 2011 Oct; 166(1):110-20. PubMed ID: 21910728
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-30 Suppresses Not Only CD4
Chen HW; Lin CI; Chuang YH
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440235
[TBL] [Abstract][Full Text] [Related]
8. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis.
Wu SJ; Yang YH; Tsuneyama K; Leung PS; Illarionov P; Gershwin ME; Chuang YH
Hepatology; 2011 Mar; 53(3):915-25. PubMed ID: 21374662
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis.
Yang YQ; Yang W; Yao Y; Ma HD; Wang YH; Li L; Wu Q; Gershwin ME; Lian ZX
Oncotarget; 2016 May; 7(19):26992-7006. PubMed ID: 27105495
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in inflamed liver are dysfunctional in murine primary biliary cholangitis.
Lin CI; Wang YW; Liu CY; Chen HW; Liang PH; Chuang YH
Clin Exp Immunol; 2024 Feb; 215(3):225-239. PubMed ID: 37916967
[TBL] [Abstract][Full Text] [Related]
12. IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression.
Gil-Fariña I; Di Scala M; Vanrell L; Olagüe C; Vales A; High KA; Prieto J; Mingozzi F; Gonzalez-Aseguinolaza G
PLoS One; 2013; 8(7):e67748. PubMed ID: 23844082
[TBL] [Abstract][Full Text] [Related]
13. Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice.
Moritoki Y; Tsuneyama K; Nakamura Y; Kikuchi K; Shiota A; Ohsugi Y; Lian ZX; Zhang W; Yang GX; Ueki S; Takeda M; Omokawa A; Saga T; Saga A; Watanabe D; Miura M; Ueno Y; Leung PSC; Tanaka A; Gershwin ME; Hirokawa M
Front Immunol; 2018; 9():2534. PubMed ID: 30450101
[TBL] [Abstract][Full Text] [Related]
14. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.
Wakabayashi K; Lian ZX; Leung PS; Moritoki Y; Tsuneyama K; Kurth MJ; Lam KS; Yoshida K; Yang GX; Hibi T; Ansari AA; Ridgway WM; Coppel RL; Mackay IR; Gershwin ME
Hepatology; 2008 Aug; 48(2):531-40. PubMed ID: 18563844
[TBL] [Abstract][Full Text] [Related]
15. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8
Ma HD; Ma WT; Liu QZ; Zhao ZB; Liu MZ; Tsuneyama K; Gao JM; Ridgway WM; Ansari AA; Gershwin ME; Fei YY; Lian ZX
J Autoimmun; 2017 Mar; 78():19-28. PubMed ID: 28129932
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
[TBL] [Abstract][Full Text] [Related]
18. The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.
Shimoda S; Tsuneyama K; Kikuchi K; Harada K; Nakanuma Y; Nakamura M; Ishibashi H; Hisamoto S; Niiro H; Leung PS; Ansari AA; Gershwin ME; Akashi K
Clin Exp Immunol; 2012 Jun; 168(3):279-84. PubMed ID: 22519590
[TBL] [Abstract][Full Text] [Related]
19. Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
Lan RY; Salunga TL; Tsuneyama K; Lian ZX; Yang GX; Hsu W; Moritoki Y; Ansari AA; Kemper C; Price J; Atkinson JP; Coppel RL; Gershwin ME
J Autoimmun; 2009 Feb; 32(1):43-51. PubMed ID: 19101114
[TBL] [Abstract][Full Text] [Related]
20. IL-21, not IL-17A, exacerbates murine primary biliary cholangitis.
Chan CW; Chen HW; Wang YW; Lin CI; Chuang YH
Clin Exp Immunol; 2024 Feb; 215(2):137-147. PubMed ID: 37708215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
